Project Grant R43AI170537

Award Date 3/11/22
Completion Date 4/30/23
Dollars Obligated $629K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Sioux Center, IA 51250, USA
Similar Awards
This $100,000 Project Grant award from the National Science Foundation (NSF) Social, Behavioral, and Economic Sciences (SBE) program (CFDA 47.075) aims to integrate wastewater surveillance and human behavior data to enhance epidemiological modeling and outbreak detection. The principal investigators at Lawrence Technological University will pursue three main objectives: (1) developing an early-warning system using wastewater and digital/social behavior data, (2) creating a...
This Project Grant award from the National Science Foundation (NSF) Directorate for Mathematical and Physical Sciences (CFDA 47.049) provides $249,313 to Lawrence Technological University to enhance dynamic population-level epidemiological models by incorporating wastewater surveillance data. The project aims to improve the estimation of true disease prevalence, enhance forecasting of future COVID-19 cases, and monitor the emergence and evolution of viral variants. Key activities include...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $142,932 to The Trustees of Columbia University in the City of New York to investigate the potential of wastewater surveillance data to improve SARS-CoV-2 dynamical modeling and forecasting. The primary objectives are to leverage a dataset from the New York State wastewater surveillance network to evaluate how incorporating wastewater data...
This $534,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to develop wastewater surveillance systems for monitoring multidrug-resistant bacteria (MDRB). The key objectives are to: Establish standardized wastewater surveillance strategies to inform clinical infection control responses, using long-read metagenomics and novel bioinformatics to rapidly identify significant changes in...
This National Science Foundation project grant award of $1,000,000 supports the establishment of the Center for Ecosystems Data Integration and Pandemic Early Warning Systems in Western New York. Funded under the NSF Engineering Directorate's Predictive Intelligence for Pandemic Prevention Phase I program, the award will support the development of an integrated early warning system to monitor and track emerging pathogens through wastewater surveillance and clinical sampling analysis....
This Project Grant, awarded by the National Science Foundation's (NSF) Division of Environmental Biology under the Biological Sciences program (CFDA 47.074), will provide $200,000 to The Johns Hopkins University to develop real-time hospitalization forecasting models for the United States. The models will leverage novel data sources like wastewater and genomic surveillance, alongside traditional epidemiological, mobility, demographic, socioeconomic, and behavioral data, to accurately assess...
This Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $995,600 to Purebiox, Inc. to develop an end-to-end solution for high-volume water microbiological testing. The project aims to enhance public health and safety by enabling early detection of waterborne viruses such as SARS-CoV-2 and norovirus, potentially weeks before outbreaks occur. The solution integrates a novel filtration cartridge and...
This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...
Fluidion US, Inc. was awarded a $256,000 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program. The grant will fund the company's development of an automated, in-situ system for high-resolution COVID-19 wastewater-based epidemiology from April 2021 through March 2023. The NSF Technology, Innovation, and Partnerships program seeks to advance science, engineering, and technology solutions to national challenges. This award will support...
The University of Texas Health Science Center at Houston received a $568,909 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct a 5-year research project titled "A Wastewater Approach to Viral Transmission, Evolution, and Ecology." The project aims to develop advanced computational models that integrate within-host viral kinetics and between-host transmission dynamics to improve...

WASTEWATER DATA INTEGRATION AND MODELLING TO ACCURATELY PREDICT COMMUNITY AND ORGANIZATIONAL OUTBREAKS DUE TO VIRAL PATHOGENS - PROJECT SUMMARY. THE COVID-19 PANDEMIC HAS MAGNIFIED THE NEED FOR ENHANCED ABILITY TO ACCURATELY ANTICIPATE FUTURE OUTBREAKS DUE TO NOVEL AND ENDEMIC VIRAL PATHOGENS. WITHOUT SYSTEMATIC SURVEILLANCE, THE ABILITY TO HEAD OFF OUTBREAKS BEFORE THEY OCCUR IS CHALLENGING: THE DATA FROM POSITIVE HUMAN TEST RESULTS IS OFTEN TOO LATE TO PREVENT A MAJOR OUTBREAK FROM OCCURRING, DESPITE SUBSTANTIAL LOCKDOWN EFFORTS. THE KEY REASON FOR THIS DELAY IS THAT PEOPLE ARE INFECTIOUS FOR DAYS BEFORE (AND IF) THEY ARE DIAGNOSED POSITIVE. WE CAN NO LONGER RELY ON POPULATION-BASED TESTING, WHICH (A) IS DELAYED; (B) IS NON-RANDOM AND EXPENSIVE, EXACERBATING WELL- KNOWN AND UNDERSTOOD HEALTH DISPARITIES; AND (C) RELIES ON HIGHLY ACCURATE, WIDELY DISTRIBUTED TEST AVAILABILITY AND USE. OVER THE LAST FOURTEEN MONTHS, OUR TEAM OF AFFILIATED SCIENTISTS HAS DEVELOPED AND IMPLEMENTED A WASTEWATER-SAMPLING APPROACH TO MONITOR FOR COVID-19 AND OTHER VIRAL PATHOGENS. OUR APPROACH UTILIZES UNIQUE GENOMIC SIGNATURES OF SARS-COV-2 (THE VIRUS THAT CAUSES COVID-19) TO DETECT THIS PATHOGEN IN WASTEWATER, PROVIDING INEXPENSIVE AND UNBIASED REAL-TIME DATA ON COVID-19 INFECTIONS IN COMMUNITIES AND ORGANIZATIONS. OUR GROUP HAS BEGUN TO CONTRACT WITH MUNICIPALITIES, ACADEMIC ENTITIES AND LARGE MANUFACTURING COMPANIES TO PROVIDE REAL-TIME, UNBIASED DATA ON THE PRESENCE OF COVID-19. CURRENTLY, HOWEVER, WASTEWATER COVID-19 DATA HAS PRIMARILY BEEN USED SOLELY TO DETERMINE THE PRESENCE/ABSENCE OF SARS-COV-2 IN SAMPLES. WE SEE A HIGHLY INNOVATIVE AND IMPACTFUL OPPORTUNITY TO LEVERAGE THESE DATA FURTHER TO ANTICIPATE THE TIMING, LOCATION, AND SEVERITY OF FUTURE OUTBREAKS FROM SARS-COV-2 AND OTHER NOVEL AND ENDEMIC VIRAL PATHOGENS. THE SUPERIOR STATISTICAL RESEARCH (SSR) R & D TEAM IS AN INTERNATIONALLY RECOGNIZED GROUP OF WASTEWATER AND PUBLIC HEALTH EXPERTS WITH CROSS-CUTTING EXPERTISE IN STATISTICS, DATA ANALYSIS, MODELLING, COMPUTING, WASTEWATER MONITORING, AND THE ABILITY TO TRANSLATE WASTEWATER AND HEALTH INFORMATION INTO ACTIONABLE STEPS FOR ORGANIZATIONS AND COMMUNITIES. TO ADDRESS THIS OPPORTUNITY, WE PROPOSE A PHASE I PROOF- OF-CONCEPT SBIR PROJECT WITH TWO AIMS. FIRST, WE WILL DEMONSTRATE THAT IT IS POSSIBLE TO ANTICIPATE LOCATIONS AND ORGANIZATIONS WITH FUTURE OUTBREAKS OF COVID-19 WITH SIGNIFICANT LEAD TIME. SECOND, WE WILL DEMONSTRATE HOW MODEL PREDICTIONS CAN BE OPTIMIZED TO BE USEFUL FOR MUNICIPALITIES AND ORGANIZATIONS. FEASIBILITY WILL BE DETERMINED BY HAVING MODELS WITH EXCELLENT PREDICTIVE ABILITY (R2>0.90) (AIM 1) AND BY DEMONSTRATING THE PROFITABILITY OF THE COMMERCIALIZATION PATHWAY (AIM 2). PHASE I FEASIBILITY WILL ALLOW US TO EXTEND MODELLING CAPABILITIES BEYOND SARS-COV-2 TO OTHER VIRAL PATHOGENS (E.G., INFLUENZA, NOROVIRUS, HIV): EXPANDING WASTEWATER TESTING CAPABILITIES FOR THESE ADDITIONAL PATHOGENS, AND FURTHER ROLL-OUT AND IMPROVEMENT OF THE MACHINE-LEARNING/MODELLING EFFORT IN PHASE II. ULTIMATELY, WE WILL HAVE A FULL-SERVICE COMMERCIAL SET OF PREDICTIVE MODELS (PHASE III) THAT CAN BE COMBINED WITH WASTEWATER-MONITORING PROGRAMS AT THE COMMUNITY AND ORGANIZATIONAL LEVEL, LEADING TO DRAMATIC REDUCTIONS IN VIRAL DISEASE OUTBREAKS.

Posted 3/11/22, 12:00 AM